In Vitro Disease Modelling as a Tool for Identifying Neurological Drug Targets

Time: 11:00 am
day: Day One


  • Exploring in vitro neurological disease modelling for identifying drug targets
  • A new approach: marrying CRISPR-based functional genomics with human hiPSC-derived disease models
  • Exploring success stories from modelling epilepsy and autism in hiPSC-derived neurons using CRISPR/Cas9 genome editing